Home › Left Ventricular Dysfunction › Georgia › Atlanta
Left Ventricular Dysfunction clinical trials in Atlanta, GA
3 studies for Left Ventricular Dysfunction are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Children's Healthcare of Atlanta - Arthur M. Blank Hospital ( Site 0001), Atlanta
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Emory University Hospital - Children's Healthcare of Atlanta Cardiology - Atlanta, Atlanta
Left Ventricular Dysfunction trials in other cities
- Cleveland, OH4 studies
- New York City, NY4 studies
- Pittsburgh, PA3 studies
- Dallas, TX3 studies
- Boston, MA3 studies
- Houston, TX3 studies
- The Bronx, NY3 studies
- Cincinnati, OH3 studies
- Aurora, CO3 studies
- St. Louis, MO3 studies
- Philadelphia, PA3 studies
- Ann Arbor, MI3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Lung Cancer29 studies
- Acute Myeloid Leukemia29 studies
- Colorectal Cancer29 studies
- Ovarian Cancer28 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
- Obesity25 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.